Stay updated on Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial page
- ChecktodayChange DetectedThe Locations section has been expanded to include numerous geographic sites across the United States, Canada, Australia, and Europe. The page layout has been reorganized to reflect these sites.SummaryDifference2%

- Check7 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2.SummaryDifference0.0%

- Check29 days agoChange DetectedA note was added to Publications clarifying that publications are provided voluntarily by the person entering study information and pertain to the study results, and the Revision label was updated to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check36 days agoChange DetectedTwo new trial locations in Tainan, Taiwan (postal codes 704 and 736) were added. The existing Tainan City entries for 704 and 736 were renamed to 'Tainan, Taiwan' with the same postal codes.SummaryDifference0.2%

- Check50 days agoChange DetectedNo significant substantive changes detected; only minor formatting differences are present. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check79 days agoChange DetectedUpdated operating status notice and version to v3.2.0; removed the specific resource “Small cell lung carcinoma” from the Genetic and Rare Diseases Information Center.SummaryDifference2%

Stay in the know with updates to Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial page.